http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202091201-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-202091201-A1 |
| titleOfInvention | COMPOSITIONS IN THE FORM OF INJECTED AQUEOUS SOLUTION CONTAINING AMILINE, AMILINE RECEPTOR AGONIST OR AMILINE ANALOGUE AND COPOLYAMINO ACID |
| abstract | The invention relates to a composition in the form of an aqueous solution for injection, for which the pH is from 6.0 to 8.0, comprising at least a) amylin, amylin receptor agonist or analog of amylin; b) a copolyamino acid bearing carboxylate charges and Hy hydrophobic radicals, wherein said copolyamino acid consists of glutamic or aspartic units and said hydrophobic Hy radicals are selected according to formula X, as defined below, characterized in that the composition does not contain basal insulin, for which the isoelectric point IP ranges from 5.8 to 8.5. This also applies to a composition characterized in that it also contains prandial insulin. |
| priorityDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.